AERAS-404

Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults

Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents

Phase II Study of H4:IC31 and BCG revaccination in Healthy Adolescents (040-404)